Novocure Ltd
NASDAQ:NVCR
Novocure Ltd
NASDAQ:NVCR
Price:
11.81
USD
-2.8%
Market Closed
Market Cap:
$1.3B
Balance Sheet
Balance Sheet Decomposition
Novocure Ltd
Novocure Ltd
Balance Sheet Decomposition is not available for
Novocure Ltd
Novocure Ltd
Balance Sheet
Novocure Ltd
Novocure Ltd
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
176
|
58
|
119
|
100
|
79
|
141
|
177
|
235
|
209
|
115
|
237
|
164
|
84
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
18
|
20
|
3
|
10
|
10
|
12
|
7
|
|
| Cash Equivalents |
176
|
58
|
119
|
100
|
79
|
141
|
159
|
214
|
206
|
106
|
227
|
152
|
76
|
|
| Short-Term Investments |
0
|
45
|
150
|
120
|
105
|
105
|
149
|
608
|
729
|
854
|
673
|
796
|
364
|
|
| Total Receivables |
3
|
4
|
8
|
12
|
33
|
41
|
64
|
101
|
111
|
106
|
72
|
99
|
115
|
|
| Accounts Receivables |
0
|
0
|
0
|
6
|
30
|
37
|
59
|
97
|
94
|
86
|
61
|
74
|
89
|
|
| Other Receivables |
0
|
0
|
0
|
6
|
3
|
5
|
6
|
4
|
17
|
20
|
11
|
25
|
26
|
|
| Inventory |
2
|
3
|
14
|
26
|
22
|
23
|
24
|
27
|
24
|
29
|
38
|
35
|
41
|
|
| Other Current Assets |
3
|
2
|
3
|
4
|
7
|
12
|
26
|
29
|
1
|
7
|
14
|
13
|
43
|
|
| Total Current Assets |
184
|
112
|
294
|
262
|
245
|
321
|
440
|
999
|
1 074
|
1 112
|
1 034
|
1 107
|
647
|
|
| PP&E Net |
5
|
6
|
13
|
19
|
18
|
15
|
35
|
42
|
54
|
69
|
98
|
120
|
147
|
|
| PP&E Gross |
5
|
6
|
13
|
19
|
18
|
15
|
35
|
42
|
54
|
69
|
98
|
120
|
147
|
|
| Accumulated Depreciation |
2
|
4
|
7
|
9
|
15
|
22
|
28
|
35
|
43
|
48
|
55
|
58
|
69
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
2
|
2
|
3
|
5
|
11
|
12
|
11
|
14
|
15
|
11
|
|
| Total Assets |
189
N/A
|
118
-38%
|
307
+161%
|
282
-8%
|
265
-6%
|
340
+28%
|
479
+41%
|
1 052
+119%
|
1 140
+8%
|
1 192
+5%
|
1 146
-4%
|
1 241
+8%
|
804
-35%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
10
|
10
|
17
|
18
|
17
|
27
|
37
|
54
|
73
|
85
|
94
|
105
|
122
|
|
| Accrued Liabilities |
5
|
6
|
8
|
8
|
13
|
17
|
21
|
30
|
46
|
47
|
59
|
56
|
76
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
558
|
0
|
|
| Other Current Liabilities |
0
|
2
|
4
|
11
|
20
|
21
|
29
|
30
|
24
|
27
|
25
|
37
|
25
|
|
| Total Current Liabilities |
16
|
18
|
29
|
37
|
50
|
65
|
86
|
114
|
143
|
159
|
179
|
756
|
223
|
|
| Long-Term Debt |
0
|
0
|
23
|
96
|
98
|
149
|
150
|
430
|
562
|
566
|
569
|
97
|
195
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
2
|
5
|
6
|
4
|
14
|
26
|
32
|
24
|
26
|
36
|
27
|
46
|
|
| Total Liabilities |
17
N/A
|
20
+17%
|
57
+183%
|
140
+147%
|
152
+9%
|
228
+50%
|
262
+15%
|
576
+120%
|
729
+27%
|
751
+3%
|
784
+4%
|
881
+12%
|
464
-47%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
196
|
277
|
388
|
520
|
582
|
644
|
651
|
631
|
686
|
779
|
986
|
1 154
|
1 290
|
|
| Additional Paid In Capital |
367
|
374
|
640
|
664
|
697
|
757
|
871
|
1 111
|
1 100
|
1 222
|
1 353
|
1 520
|
1 634
|
|
| Other Equity |
0
|
0
|
2
|
2
|
1
|
1
|
3
|
4
|
3
|
2
|
5
|
6
|
3
|
|
| Total Equity |
172
N/A
|
98
-43%
|
251
+156%
|
142
-43%
|
114
-20%
|
112
-1%
|
218
+94%
|
477
+119%
|
411
-14%
|
441
+7%
|
362
-18%
|
360
-1%
|
340
-5%
|
|
| Total Liabilities & Equity |
189
N/A
|
118
-38%
|
307
+161%
|
282
-8%
|
265
-6%
|
340
+28%
|
479
+41%
|
1 052
+119%
|
1 140
+8%
|
1 192
+5%
|
1 146
-4%
|
1 241
+8%
|
804
-35%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
83
|
83
|
84
|
87
|
90
|
93
|
100
|
102
|
104
|
105
|
107
|
109
|
112
|
|
Switch to:
Switch to:
See Also
Discover More
